| __timestamp | Amphastar Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51256000 | 2614539000 |
| Thursday, January 1, 2015 | 77347000 | 3711019000 |
| Friday, January 1, 2016 | 104189000 | 4560733000 |
| Sunday, January 1, 2017 | 90795000 | 5475166000 |
| Monday, January 1, 2018 | 106985000 | 6276700000 |
| Tuesday, January 1, 2019 | 131923000 | 7081200000 |
| Wednesday, January 1, 2020 | 143340000 | 7377200000 |
| Friday, January 1, 2021 | 199739000 | 13634200000 |
| Saturday, January 1, 2022 | 248860000 | 10612500000 |
| Sunday, January 1, 2023 | 351121000 | 11301400000 |
| Monday, January 1, 2024 | 12231500000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, gross profit is a key indicator of a company's financial health and market prowess. Over the past decade, Regeneron Pharmaceuticals, Inc. has consistently outperformed Amphastar Pharmaceuticals, Inc. in terms of gross profit. From 2014 to 2023, Regeneron's gross profit surged by approximately 332%, peaking at over $11 billion in 2023. In contrast, Amphastar's growth, while commendable, was more modest, with a 585% increase, reaching around $351 million in the same year.
This stark difference highlights Regeneron's dominant position in the industry, driven by its innovative drug pipeline and strategic market expansions. Meanwhile, Amphastar's steady growth reflects its focus on niche markets and cost-effective production. As the pharmaceutical landscape evolves, these companies' financial trajectories offer valuable insights into their strategic directions and market adaptability.
Gross Profit Comparison: Merck & Co., Inc. and Amphastar Pharmaceuticals, Inc. Trends
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Zoetis Inc. vs Amphastar Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc: A Detailed Gross Profit Analysis
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Regeneron Pharmaceuticals, Inc. and MorphoSys AG
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Gross Profit Comparison: Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc. Trends
Gross Profit Trends Compared: Pharming Group N.V. vs Amphastar Pharmaceuticals, Inc.
Gross Profit Trends Compared: Arrowhead Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.